Evidence map›Paper›PMID 31504860›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

Smoking Cessation, Weight Gain, and the Trajectory of Estimated Risk of Coronary Heart Disease: 8-Year Follow-up From a Prospective Cohort Study.

Sanmei Chen, Yohei Kawasaki, Huanhuan Hu, Keisuke Kuwahara, Makoto Yamamoto, Akihiko Uehara, Toru Honda, Shuichiro Yamamoto, Tohru Nakagawa, Toshiaki Miyamoto and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. A randomized controlled trial to reduce post-cessation weight gain.International journal of obesity (2005) · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Missense Variant rs28362680 inPharmacogenomics and personalized medicine · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 1 country.

Sanmei ChenDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Yohei KawasakiBiostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan.
Huanhuan HuDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Keisuke KuwaharaDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Makoto YamamotoYamaha Corporation, Shizuoka, Japan.
Akihiko UeharaSeijinkai Shizunai Hospital, Hokkaidō, Japan.
Toru HondaHitachi, Ltd, Ibaraki, Japan.
Shuichiro YamamotoHitachi, Ltd, Ibaraki, Japan.
Tohru NakagawaHitachi, Ltd, Ibaraki, Japan.
Toshiaki MiyamotoNIPPON STEEL CORPORATION Kimitsu Works, Chiba, Japan.
Hiroko OkazakiMitsui Chemicals, Inc, Tokyo, Japan.
Ai HoriDepartment of Global Public Health, University of Tsukuba, Ibaraki, Japan.
Makiko ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.
Taizo MurakamiMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.
Takeshi KochiFurukawa Electric Co, Ltd, Tokyo, Japan.
Masafumi EguchiFurukawa Electric Co, Ltd, Tokyo, Japan.
Teppei ImaiAzbil Corporation, Tokyo, Japan.
Akiko NishiharaAzbil Corporation, Tokyo, Japan.
Kentaro TomitaHealthplant Co, Tokyo, Japan.
Shamima AkterDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Isamu KabeTsukuba Plant, Kubota Co, Ibaraki, Japan.
Tetsuya MizoueDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Seitaro DohiMitsui Chemicals, Inc, Tokyo, Japan.
National Center for Global Health and Medicine · JPHitachi (Japan) · JPAzbil (Japan) · JPFurukawa Electric (Japan) · JPKeihin (Japan) · JPMitsui Chemicals (Japan) · JPChiba University Hospital · JPKubota (Japan) · JPNippon Steel (Japan) · JPUniversity of Tsukuba · JPYamaha (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe effect of weight gain following smoking cessation on cardiovascular risks is unclear. We aimed to prospectively investigate the association of weight gain following smoking cessation with the trajectory of estimated risks of coronary heart disease (CHD).

methodsIn a cohort of 18 562 Japanese male employees aged 30-64 years and initially free of cardiovascular diseases, participants were exclusively grouped into sustained smokers, quitters with weight gain (body weight increase ≥5%), quitters without weight gain (body weight increase <5% or weight loss), and never smokers. Global 10-year CHD risk was annually estimated by using a well-validated prediction model for the Japanese population. Linear mixed models and piecewise linear mixed models were used to compare changes in the estimated 10-year CHD risk by smoking status and weight change following smoking cessation.

resultsDuring a maximum of 8-year follow-up, both quitters with and without weight gain had a substantially decreased level of estimated 10-year CHD risk after quitting smoking, compared with sustained smokers (all ps for mean differences < .001). The estimated 10-year CHD risk within the first year after cessation decreased more rapidly in quitters without weight gain than in quitters with weight gain (change rate [95% confidence interval, CI] -0.90 [-1.04 to -0.75] vs. -0.40 [-0.60 to -0.19] % per year, p < .0001). Thereafter, the estimated 10-year CHD risk in both groups increased at similar rates (change rate [95% CI] -0.07 [-0.21 to 0.07] vs. 0.11 [-0.09 to 0.30] % per year, p = .16, from year 1 to year 2; and 0.10 [0.05 to 0.15] vs. 0.11 [0.04 to 0.18] % per year, p = .80, from year 2 to year 8).

conclusionsIn this population of middle-aged, Japanese male workers, smoking cessation greatly reduces the estimated 10-year risk of CHD. However, weight gain weakens the beneficial effect of quitting smoking in a temporary and limited fashion. IMPLICATIONS: To the best of our knowledge, this study is the first to examine the effect of weight gain following smoking cessation on the trajectory of the absolute risk of CHD. Our data imply that the benefits of cessation for reducing the absolute risk of CHD outweigh the potential risk increase due to weight gain, and suggest that in order to maximize the beneficial effects of quitting smoking, interventions to control post-cessation weight gain might be warranted.

Indexed as

Weight GainAdultCardiovascular DiseasesFollow-Up StudiesHumansIncidenceJapanMaleMiddle AgedProspective StudiesRisk FactorsSmokingSmoking Cessation

Identifiers

PMID31504860
PMCPMC7789946
OpenAlexW2970487492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.